Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus

Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,833 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus trial results

Recruiting

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

NCT07115953

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Diseases, +18 more
Locations
  • The Alfred Hospital Melbourne, Australia
  • Royal Perth Hospital Perth, Australia
  • Ziekenhuis Oost Limburg Genk, Limburg, Belgium
  • CHC MontLégia Liège, Belgium
View all 21 locations
View Trial Details
Recruiting

SPYRAL GEMINI Pilot Study

NCT06907147

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Diseases, +18 more
Locations
  • Stanford Hospital and Clinics Stanford, California, United States
  • Orlando Health Heart & Vascular Institute Orlando, Florida, United States
  • BayCare Health System Mease Countryside Hospital Safety Harbor, Florida, United States
  • Piedmont Heart Institute Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Recruiting

SPARK-CGM Implementation

NCT07548372

Conditions
Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
Locations
  • Montefiore Medical Group (MMG) The Bronx, New York, United States
View Trial Details
Recruiting

Swiss Diabetes Registry - SwissDiab Study

NCT01179815

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern Bern, Switzerland
  • Service d'endocrinologie, diabétologie et métabolisme Lausanne, Switzerland
  • Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen Sankt Gallen, Switzerland
  • Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich Zurich, Switzerland
View Trial Details
Recruiting

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

NCT07621419

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Hospital General de Agudos Dr Enrique Tornú Buenos Aires, Argentina
View Trial Details

Related conditions